Responsabilidade civil farmacêutica por reações adversas (graves e inesperadas) medicamentosas

Abstract

This paper analyzes the effects of product liability law under adverse reactions caused by defective drugs. The main goal was to examine: initially, in a pre-commercial stage, in a controlled clinical trial environment, a direct responsibility of the pharmaceutical manufacturing company, just because it is the one that fits the interests at stake; and then, after the placement of the defective drug in the consumer’s market, the confrontation between national realities (common products liability on one hand, and the expectations of a special treatment on the other) and Europeans’ (from the European Union products liability law to the member states attempts to overcome adversities), against the dangers of pharmaceutical companies, whose development risks marked the world history.

Date of Award	25 Sept 2015
Original language	Portuguese
Awarding Institution	Universidade Católica Portuguesa
Supervisor	José Carlos Barros Brandão Proença (Supervisor)